Search results for “site:ncbi.nlm.nih.gov”

Page 20 of about 437 results

ncbi.nlm.nih.gov pubmed › 32278065

Diarrhea During COVID-19 Infection: Pathogenesis, Epidemiology, Prevention, and Management

The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2/COVID-19) pandemic is a worldwide emergency. An increasing number of diarrhea cases is reported. Here we investigate the epidemiology, clinical presentation, molecular...

ncbi.nlm.nih.gov pubmed › 32278764

COVID-19 and diabetes: Knowledge in progress

Suggestions are made on the possible pathophysiological mechanisms of the relationship between diabetes and COVID-19, and its management. No definite conclusions can be made based on current limited evidence. Further research regarding this relationship and its clinical management is warranted.

ncbi.nlm.nih.gov pubmed › 32283152

The pathogenesis and treatment of the `Cytokine Storm' in COVID-19

Cytokine storm is an excessive immune response to external stimuli. The pathogenesis of the cytokine storm is complex. The disease progresses rapidly, and the mortality is high. Certain evidence shows that, during the coronavirus disease...

ncbi.nlm.nih.gov pubmed › 32284146

Keratoconjunctivitis as the initial medical presentation of the novel coronavirus disease 2019 (COVID-19)

Keratoconjunctivitis as the initial medical presentation of the novel coronavirus disease 2019 (COVID-19)

ncbi.nlm.nih.gov pubmed › 32291098

Assessing Viral Shedding and Infectivity of Tears in Coronavirus Disease 2019 (COVID-19) Patients

Assessing Viral Shedding and Infectivity of Tears in Coronavirus Disease 2019 (COVID-19) Patients

ncbi.nlm.nih.gov pubmed › 32293835

COVID-19: Prevention and control measures in community

On January 30, 2020, the WHO declared the COVID-19 outbreak a public health emergency of international concern and, in March 2020, began to characterize it as a pandemic in order to emphasize the gravity of the situation and urge all...

ncbi.nlm.nih.gov pubmed › 32302448

The procoagulant pattern of patients with COVID-19 acute respiratory distress syndrome

The pro-coagulant pattern of these patients may justify the clinical reports of thromboembolic complications (pulmonary embolism) during the course of the disease. Further studies are needed to assess the best prophylaxis and treatment of this condition.

ncbi.nlm.nih.gov pubmed › 32302812

Assessing nitrogen dioxide (NO2) levels as a contributing factor to coronavirus (COVID-19) fatality

Nitrogen dioxide (NO<sub>2</sub>) is an ambient trace-gas result of both natural and anthropogenic processes. Long-term exposure to NO<sub>2</sub> may cause a wide spectrum of severe health problems such as hypertension, diabetes, heart...

ncbi.nlm.nih.gov pubmed › 32310612

Cardiac Manifestations of Coronavirus (COVID-19)

Coronaviruses are a large family of single-stranded positive-sense, enveloped RNA viruses that can infect many animal species. Human coronaviruses can be divided based on their pathogenicity. The types with high pathogenicity include...

ncbi.nlm.nih.gov pubmed › 32311448

COVID-19 and Thrombotic or Thromboembolic Disease: Implications for Prevention, Antithrombotic Therapy, and Follow-Up: JACC State-of-the-Art Review

Coronavirus disease-2019 (COVID-19), a viral respiratory illness caused by the severe acute respiratory syndrome-coronavirus-2 (SARS-CoV-2), may predispose patients to thrombotic disease, both in the venous and arterial circulations,...

Try “site:ncbi.nlm.nih.gov” on: Marginalia · Mojeek · Wiby · DuckDuckGo · Bing · Google · Wikipedia · Internet Archive